Innova Captab Limited (NSE:INNOVACAP)
860.80
+10.40 (1.22%)
Jun 1, 2026, 3:29 PM IST
Innova Captab Revenue
In the fiscal year ending March 31, 2026, Innova Captab had annual revenue of 16.30B INR with 31.06% growth. Innova Captab had revenue of 4.48B in the quarter ending March 31, 2026, with 42.28% growth.
Revenue
16.30B
Revenue Growth
+31.06%
P/S Ratio
2.99
Revenue / Employee
10.19M
Employees
1,600
Market Cap
48.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 16.30B | 3.86B | 31.06% |
| Mar 31, 2025 | 12.44B | 1.62B | 15.02% |
| Mar 31, 2024 | 10.81B | 1.55B | 16.72% |
| Mar 31, 2023 | 9.26B | 1.26B | 15.72% |
| Mar 31, 2022 | 8.01B | 3.90B | 94.94% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 48.59B |
| Akums Drugs and Pharmaceuticals | 43.59B |
| Alivus Life Sciences | 25.52B |
| Indoco Remedies | 18.45B |
| Aarti Pharmalabs | 18.29B |
| Solara Active Pharma Sciences | 13.75B |
| Orchid Pharma | 8.47B |
| RPG Life Sciences | 7.08B |